Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Compass Therapeutics (CMPX) EBIT Margin (2024)

Historic EBIT Margin for Compass Therapeutics (CMPX) over the last 1 years, with Q2 2024 value amounting to 1770.0%.

  • Compass Therapeutics' EBIT Margin changed N/A to 1770.0% in Q2 2024 from the same period last year, while for Mar 2025 it was 7273.41%, marking a year-over-year change of. This contributed to the annual value of 6661.76% for FY2024, which is N/A changed from last year.
  • Compass Therapeutics' EBIT Margin amounted to 1770.0% in Q2 2024.
  • In the past 5 years, Compass Therapeutics' EBIT Margin ranged from a high of 1770.0% in Q2 2024 and a low of 1770.0% during Q2 2024